 | • レポートコード：MRC2102QY6592 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のヒストンデアセチラーゼ阻害剤市場について種類別（競合阻害剤、非競合阻害剤、混合阻害剤）、用途別（精神・神経、癌治療、炎症性疾患、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヒストンデアセチラーゼ阻害剤市場の概要 ・世界の主要地域別ヒストンデアセチラーゼ阻害剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒストンデアセチラーゼ阻害剤市場規模2015-2026：種類別（競合阻害剤、非競合阻害剤、混合阻害剤） ・世界のヒストンデアセチラーゼ阻害剤市場規模2015-2026：用途別（精神・神経、癌治療、炎症性疾患、その他） ・ヒストンデアセチラーゼ阻害剤の米国市場規模2015-2020 ・ヒストンデアセチラーゼ阻害剤のヨーロッパ市場規模2015-2020 ・ヒストンデアセチラーゼ阻害剤の中国市場規模2015-2020 ・ヒストンデアセチラーゼ阻害剤の日本市場規模2015-2020 ・ヒストンデアセチラーゼ阻害剤の東南アジア市場規模2015-2020 ・ヒストンデアセチラーゼ阻害剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ヒストンデアセチラーゼ阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒストンデアセチラーゼ阻害剤の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Histone Deacetylase Inhibitors Market
The global Histone Deacetylase Inhibitors market size is projected to reach US$ 2043.7 million by 2026, from US$ 1028 million in 2020, at a CAGR of 12.1% during 2021-2026.
Global Histone Deacetylase Inhibitors Scope and Market Size
The global Histone Deacetylase Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Histone Deacetylase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Histone Deacetylase Inhibitors market is segmented into
Competitive Inhibitors
Uncompetitive Inhibitors
Mixed Inhibitors
Segment by Application, the Histone Deacetylase Inhibitors market is segmented into
Psychiatry and Neurology
Cancer Treatment
Inflammatory Diseases
Other Diseases
The Histone Deacetylase Inhibitors market is analysed and market size information is provided by regions (countries). Segment by Application, the Histone Deacetylase Inhibitors market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Histone Deacetylase Inhibitors Market Share Analysis
Histone Deacetylase Inhibitors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Histone Deacetylase Inhibitors business, the date to enter into the Histone Deacetylase Inhibitors market, Histone Deacetylase Inhibitors product introduction, recent developments, etc.
The major vendors covered:
4SC AG
Acetylon Pharmaceuticals
Celleron Therapeutics
Chroma Therapeutics
CrystalGenomics
Curis
MEI Pharma
Mirati Therapeutics
Novartis
Onxeo
Repligen
TetraLogic
1 Histone Deacetylase Inhibitors Market Overview
1.1 Histone Deacetylase Inhibitors Product Scope
1.2 Histone Deacetylase Inhibitors Segment by Type
1.2.1 Global Histone Deacetylase Inhibitors Sales by Type (2020-2026)
1.2.2 Competitive Inhibitors
1.2.3 Uncompetitive Inhibitors
1.2.4 Mixed Inhibitors
1.3 Histone Deacetylase Inhibitors Segment by Application
1.3.1 Global Histone Deacetylase Inhibitors Sales Comparison by Application (2020-2026)
1.3.2 Psychiatry and Neurology
1.3.3 Cancer Treatment
1.3.4 Inflammatory Diseases
1.3.5 Other Diseases
1.4 Histone Deacetylase Inhibitors Market Estimates and Forecasts (2015-2026)
1.4.1 Global Histone Deacetylase Inhibitors Sales Growth Rate (2015-2026)
1.4.2 Global Histone Deacetylase Inhibitors Revenue and Growth Rate (2015-2026)
1.4.3 Global Histone Deacetylase Inhibitors Price Trends (2015-2026)
2 Histone Deacetylase Inhibitors Estimate and Forecast by Region
2.1 Global Histone Deacetylase Inhibitors Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Histone Deacetylase Inhibitors Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Histone Deacetylase Inhibitors Sales Market Share by Region (2015-2020)
2.2.2 Global Histone Deacetylase Inhibitors Revenue Market Share by Region (2015-2020)
2.3 Global Histone Deacetylase Inhibitors Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Histone Deacetylase Inhibitors Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Histone Deacetylase Inhibitors Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Histone Deacetylase Inhibitors Estimates and Projections (2015-2026)
2.4.2 Europe Histone Deacetylase Inhibitors Estimates and Projections (2015-2026)
2.4.3 China Histone Deacetylase Inhibitors Estimates and Projections (2015-2026)
2.4.4 Japan Histone Deacetylase Inhibitors Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Histone Deacetylase Inhibitors Estimates and Projections (2015-2026)
2.4.6 India Histone Deacetylase Inhibitors Estimates and Projections (2015-2026)
3 Global Histone Deacetylase Inhibitors Competition Landscape by Players
3.1 Global Top Histone Deacetylase Inhibitors Players by Sales (2015-2020)
3.2 Global Top Histone Deacetylase Inhibitors Players by Revenue (2015-2020)
3.3 Global Histone Deacetylase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Histone Deacetylase Inhibitors as of 2019)
3.4 Global Histone Deacetylase Inhibitors Average Price by Company (2015-2020)
3.5 Manufacturers Histone Deacetylase Inhibitors Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Histone Deacetylase Inhibitors Players (Opinion Leaders)
4 Global Histone Deacetylase Inhibitors Market Size by Type
4.1 Global Histone Deacetylase Inhibitors Historic Market Review by Type (2015-2020)
4.1.1 Global Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
4.1.2 Global Histone Deacetylase Inhibitors Revenue Market Share by Type (2015-2020)
4.1.3 Global Histone Deacetylase Inhibitors Price by Type (2015-2020)
4.2 Global Histone Deacetylase Inhibitors Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Histone Deacetylase Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Histone Deacetylase Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Global Histone Deacetylase Inhibitors Price Forecast by Type (2021-2026)
5 Global Histone Deacetylase Inhibitors Market Size by Application
5.1 Global Histone Deacetylase Inhibitors Historic Market Review by Application (2015-2020)
5.1.1 Global Histone Deacetylase Inhibitors Sales Market Share by Application (2015-2020)
5.1.2 Global Histone Deacetylase Inhibitors Revenue Market Share by Application (2015-2020)
5.1.3 Global Histone Deacetylase Inhibitors Price by Application (2015-2020)
5.2 Global Histone Deacetylase Inhibitors Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Histone Deacetylase Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Histone Deacetylase Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Histone Deacetylase Inhibitors Price Forecast by Application (2021-2026)
6 United States Histone Deacetylase Inhibitors Market Facts & Figures
6.1 United States Histone Deacetylase Inhibitors Sales Market Share by Company (2015-2020)
6.2 United States Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
6.3 United States Histone Deacetylase Inhibitors Sales Market Share by Application (2015-2020)
7 Europe Histone Deacetylase Inhibitors Market Facts & Figures
7.1 Europe Histone Deacetylase Inhibitors Sales Market Share by Company (2015-2020)
7.2 Europe Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
7.3 Europe Histone Deacetylase Inhibitors Sales Market Share by Application (2015-2020)
8 China Histone Deacetylase Inhibitors Market Facts & Figures
8.1 China Histone Deacetylase Inhibitors Sales Market Share by Company (2015-2020)
8.2 China Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
8.3 China Histone Deacetylase Inhibitors Sales Market Share by Application (2015-2020)
9 Japan Histone Deacetylase Inhibitors Market Facts & Figures
9.1 Japan Histone Deacetylase Inhibitors Sales Market Share by Company (3015-3030)
9.2 Japan Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
9.3 Japan Histone Deacetylase Inhibitors Sales Market Share by Application (2015-2020)
10 Southeast Asia Histone Deacetylase Inhibitors Market Facts & Figures
10.1 Southeast Asia Histone Deacetylase Inhibitors Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Histone Deacetylase Inhibitors Sales Market Share by Application (2015-2020)
11 India Histone Deacetylase Inhibitors Market Facts & Figures
11.1 India Histone Deacetylase Inhibitors Sales Market Share by Company (2015-2020)
11.2 India Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
11.3 India Histone Deacetylase Inhibitors Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Histone Deacetylase Inhibitors Business
12.1 4SC AG
12.1.1 4SC AG Corporation Information
12.1.2 4SC AG Business Overview
12.1.3 4SC AG Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.1.4 4SC AG Histone Deacetylase Inhibitors Products Offered
12.1.5 4SC AG Recent Development
12.2 Acetylon Pharmaceuticals
12.2.1 Acetylon Pharmaceuticals Corporation Information
12.2.2 Acetylon Pharmaceuticals Business Overview
12.2.3 Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Products Offered
12.2.5 Acetylon Pharmaceuticals Recent Development
12.3 Celleron Therapeutics
12.3.1 Celleron Therapeutics Corporation Information
12.3.2 Celleron Therapeutics Business Overview
12.3.3 Celleron Therapeutics Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Celleron Therapeutics Histone Deacetylase Inhibitors Products Offered
12.3.5 Celleron Therapeutics Recent Development
12.4 Chroma Therapeutics
12.4.1 Chroma Therapeutics Corporation Information
12.4.2 Chroma Therapeutics Business Overview
12.4.3 Chroma Therapeutics Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Chroma Therapeutics Histone Deacetylase Inhibitors Products Offered
12.4.5 Chroma Therapeutics Recent Development
12.5 CrystalGenomics
12.5.1 CrystalGenomics Corporation Information
12.5.2 CrystalGenomics Business Overview
12.5.3 CrystalGenomics Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.5.4 CrystalGenomics Histone Deacetylase Inhibitors Products Offered
12.5.5 CrystalGenomics Recent Development
12.6 Curis
12.6.1 Curis Corporation Information
12.6.2 Curis Business Overview
12.6.3 Curis Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Curis Histone Deacetylase Inhibitors Products Offered
12.6.5 Curis Recent Development
12.7 MEI Pharma
12.7.1 MEI Pharma Corporation Information
12.7.2 MEI Pharma Business Overview
12.7.3 MEI Pharma Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.7.4 MEI Pharma Histone Deacetylase Inhibitors Products Offered
12.7.5 MEI Pharma Recent Development
12.8 Mirati Therapeutics
12.8.1 Mirati Therapeutics Corporation Information
12.8.2 Mirati Therapeutics Business Overview
12.8.3 Mirati Therapeutics Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Mirati Therapeutics Histone Deacetylase Inhibitors Products Offered
12.8.5 Mirati Therapeutics Recent Development
12.9 Novartis
12.9.1 Novartis Corporation Information
12.9.2 Novartis Business Overview
12.9.3 Novartis Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Novartis Histone Deacetylase Inhibitors Products Offered
12.9.5 Novartis Recent Development
12.10 Onxeo
12.10.1 Onxeo Corporation Information
12.10.2 Onxeo Business Overview
12.10.3 Onxeo Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Onxeo Histone Deacetylase Inhibitors Products Offered
12.10.5 Onxeo Recent Development
12.11 Repligen
12.11.1 Repligen Corporation Information
12.11.2 Repligen Business Overview
12.11.3 Repligen Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Repligen Histone Deacetylase Inhibitors Products Offered
12.11.5 Repligen Recent Development
12.12 TetraLogic
12.12.1 TetraLogic Corporation Information
12.12.2 TetraLogic Business Overview
12.12.3 TetraLogic Histone Deacetylase Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.12.4 TetraLogic Histone Deacetylase Inhibitors Products Offered
12.12.5 TetraLogic Recent Development
13 Histone Deacetylase Inhibitors Manufacturing Cost Analysis
13.1 Histone Deacetylase Inhibitors Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Histone Deacetylase Inhibitors
13.4 Histone Deacetylase Inhibitors Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Histone Deacetylase Inhibitors Distributors List
14.3 Histone Deacetylase Inhibitors Customers
15 Market Dynamics
15.1 Histone Deacetylase Inhibitors Market Trends
15.2 Histone Deacetylase Inhibitors Opportunities and Drivers
15.3 Histone Deacetylase Inhibitors Market Challenges
15.4 Histone Deacetylase Inhibitors Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Histone Deacetylase Inhibitors Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Histone Deacetylase Inhibitors Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Histone Deacetylase Inhibitors Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Histone Deacetylase Inhibitors Sales (K MT) by Region (2015-2020)
Table 5. Global Histone Deacetylase Inhibitors Sales Market Share by Region (2015-2020)
Table 6. Global Histone Deacetylase Inhibitors Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Histone Deacetylase Inhibitors Revenue Share by Region (2015-2020)
Table 8. Global Histone Deacetylase Inhibitors Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Histone Deacetylase Inhibitors Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Histone Deacetylase Inhibitors Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Histone Deacetylase Inhibitors Revenue Share Forecast by Region (2021-2026)
Table 12. Global Histone Deacetylase Inhibitors (K MT) of Key Companies (2015-2020)
Table 13. Global Histone Deacetylase Inhibitors Sales Share by Company (2015-2020)
Table 14. Global Histone Deacetylase Inhibitors Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Histone Deacetylase Inhibitors Revenue Share by Company (2015-2020)
Table 16. Global Histone Deacetylase Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Histone Deacetylase Inhibitors as of 2019)
Table 17. Global Histone Deacetylase Inhibitors Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Histone Deacetylase Inhibitors Manufacturing Sites and Area Served
Table 19. Manufacturers Histone Deacetylase Inhibitors Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Histone Deacetylase Inhibitors Players
Table 22. Global Histone Deacetylase Inhibitors Sales (K MT) by Type (2015-2020)
Table 23. Global Histone Deacetylase Inhibitors Sales Share by Type (2015-2020)
Table 24. Global Histone Deacetylase Inhibitors Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Histone Deacetylase Inhibitors Price (K MT) by Type (2015-2020)
Table 26. Global Histone Deacetylase Inhibitors Sales Share by Type (2021-2026)
Table 27. Global Histone Deacetylase Inhibitors Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Histone Deacetylase Inhibitors Revenue Share by Type (2021-2026)
Table 29. Global Histone Deacetylase Inhibitors Price (K MT) by Type (2021-2026)
Table 30. Global Histone Deacetylase Inhibitors Sales (K MT) by Application (2015-2020)
Table 31. Global Histone Deacetylase Inhibitors Sales Share by Application (2015-2020)
Table 32. Global Histone Deacetylase Inhibitors Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Histone Deacetylase Inhibitors Price (K MT) by Application (2015-2020)
Table 34. Global Histone Deacetylase Inhibitors Sales (K MT) by Application (2021-2026)
Table 35. Global Histone Deacetylase Inhibitors Sales Share by Application (2021-2026)
Table 36. Global Histone Deacetylase Inhibitors Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Histone Deacetylase Inhibitors Revenue Share by Application (2021-2026)
Table 38. Global Histone Deacetylase Inhibitors Price (K MT) by Application (2021-2026)
Table 39. United States Histone Deacetylase Inhibitors Sales (K MT) by Company (2015-2020)
Table 40. United States Histone Deacetylase Inhibitors Sales Market Share by Company (2015-2020)
Table 41. United States Histone Deacetylase Inhibitors Sales (K MT) by Type (2015-2020)
Table 42. United States Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
Table 43. United States Histone Deacetylase Inhibitors Sales (K MT) by Application (2015-2020)
Table 44. United States Histone Deacetylase Inhibitors Sales Market Share by Application (2015-2020)
Table 45. Europe Histone Deacetylase Inhibitors Sales (K MT) by Company (2015-2020)
Table 46. Europe Histone Deacetylase Inhibitors Sales Market Share by Company (2015-2020)
Table 47. Europe Histone Deacetylase Inhibitors Sales (K MT) by Type (2015-2020)
Table 48. Europe Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
Table 49. Europe Histone Deacetylase Inhibitors Sales (K MT) by Application (2015-2020)
Table 50. Europe Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
Table 51. China Histone Deacetylase Inhibitors Sales (K MT) by Company (2015-2020)
Table 52. China Histone Deacetylase Inhibitors Sales Market Share by Company (2015-2020)
Table 53. China Histone Deacetylase Inhibitors Sales (K MT) by Type (2015-2020)
Table 54. China Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
Table 55. China Histone Deacetylase Inhibitors Sales (K MT) by Application (2015-2020)
Table 56. China Histone Deacetylase Inhibitors Sales Market Share by Application (2015-2020)
Table 57. Japan Histone Deacetylase Inhibitors Sales (K MT) by Company (2015-2020)
Table 58. Japan Histone Deacetylase Inhibitors Sales Market Share by Company (2015-2020)
Table 59. Japan Histone Deacetylase Inhibitors Sales (K MT) by Type (2015-2020)
Table 60. Japan Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
Table 61. Japan Histone Deacetylase Inhibitors Sales (K MT) by Application (2015-2020)
Table 62. Japan Histone Deacetylase Inhibitors Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Histone Deacetylase Inhibitors Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Histone Deacetylase Inhibitors Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Histone Deacetylase Inhibitors Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Histone Deacetylase Inhibitors Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Histone Deacetylase Inhibitors Sales Market Share by Application (2015-2020)
Table 69. India Histone Deacetylase Inhibitors Sales (K MT) by Company (2015-2020)
Table 70. India Histone Deacetylase Inhibitors Sales Market Share by Company (2015-2020)
Table 71. India Histone Deacetylase Inhibitors Sales (K MT) by Type (2015-2020)
Table 72. India Histone Deacetylase Inhibitors Sales Market Share by Type (2015-2020)
Table 73. India Histone Deacetylase Inhibitors Sales (K MT) by Application (2015-2020)
Table 74. India Histone Deacetylase Inhibitors Sales Market Share by Application (2015-2020)
Table 75. 4SC AG Corporation Information
Table 76. 4SC AG Description and Business Overview
Table 77. 4SC AG Histone Deacetylase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. 4SC AG Histone Deacetylase Inhibitors Product
Table 79. 4SC AG Recent Development
Table 80. Acetylon Pharmaceuticals Corporation Information
Table 81. Acetylon Pharmaceuticals Description and Business Overview
Table 82. Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Acetylon Pharmaceuticals Histone Deacetylase Inhibitors Product
Table 84. Acetylon Pharmaceuticals Recent Development
Table 85. Celleron Therapeutics Corporation Information
Table 86. Celleron Therapeutics Description and Business Overview
Table 87. Celleron Therapeutics Histone Deacetylase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Celleron Therapeutics Histone Deacetylase Inhibitors Product
Table 89. Celleron Therapeutics Recent Development
Table 90. Chroma Therapeutics Corporation Information
Table 91. Chroma Therapeutics Description and Business Overview
Table 92. Chroma Therapeutics Histone Deacetylase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Chroma Therapeutics Histone Deacetylase Inhibitors Product
Table 94. Chroma Therapeutics Recent Development
Table 95. CrystalGenomics Corporation Information
Table 96. CrystalGenomics Description and Business Overview
Table 97. CrystalGenomics Histone Deacetylase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. CrystalGenomics Histone Deacetylase Inhibitors Product
Table 99. CrystalGenomics Recent Development
Table 100. Curis Corporation Information
Table 101. Curis Description and Business Overview
Table 102. Curis Histone Deacetylase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Curis Histone Deacetylase Inhibitors Product
Table 104. Curis Recent Development
Table 105. MEI Pharma Corporation Information
Table 106. MEI Pharma Description and Business Overview
Table 107. MEI Pharma Histone Deacetylase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. MEI Pharma Histone Deacetylase Inhibitors Product
Table 109. MEI Pharma Recent Development
Table 110. Mirati Therapeutics Corporation Information
Table 111. Mirati Therapeutics Histone Deacetylase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Mirati Therapeutics Description and Business Overview
Table 113. Mirati Therapeutics Histone Deacetylase Inhibitors Product
Table 114. Mirati Therapeutics Recent Development
Table 115. Novartis Corporation Information
Table 116. Novartis Histone Deacetylase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Novartis Description and Business Overview
Table 118. Novartis Histone Deacetylase Inhibitors Product
Table 119. Novartis Recent Development
Table 120. Onxeo Corporation Information
Table 121. Onxeo Description and Business Overview
Table 122. Onxeo Histone Deacetylase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Onxeo Histone Deacetylase Inhibitors Product
Table 124. Onxeo Recent Development
Table 125. Repligen Corporation Information
Table 126. Repligen Description and Business Overview
Table 127. Repligen Histone Deacetylase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Repligen Histone Deacetylase Inhibitors Product
Table 129. Repligen Recent Development
Table 130. TetraLogic Corporation Information
Table 131. TetraLogic Description and Business Overview
Table 132. TetraLogic Histone Deacetylase Inhibitors Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. TetraLogic Histone Deacetylase Inhibitors Product
Table 134. TetraLogic Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Histone Deacetylase Inhibitors Distributors List
Table 138. Histone Deacetylase Inhibitors Customers List
Table 139. Histone Deacetylase Inhibitors Market Key Trends
Table 140. Histone Deacetylase Inhibitors Key Opportunities and Drivers
Table 141. Histone Deacetylase Inhibitors Market Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Histone Deacetylase Inhibitors Product Picture
Figure 2. Global Histone Deacetylase Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Histone Deacetylase Inhibitors Market Share by Application in 2020 & 2026
Figure 6. Psychiatry and Neurology Examples
Figure 7. Cancer Treatment Examples
Figure 8. Inflammatory Diseases Examples
Figure 9. Other Diseases Examples
Figure 10. Global Histone Deacetylase Inhibitors Sales (K MT) Growth Rate (2015-2026)
Figure 11. Global Histone Deacetylase Inhibitors Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Histone Deacetylase Inhibitors Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 13. Global Histone Deacetylase Inhibitors Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Histone Deacetylase Inhibitors Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Histone Deacetylase Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Histone Deacetylase Inhibitors Sales (K MT) Growth Rate (2015-2026)
Figure 17. Europe Histone Deacetylase Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Histone Deacetylase Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Histone Deacetylase Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Histone Deacetylase Inhibitors Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Histone Deacetylase Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Histone Deacetylase Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Histone Deacetylase Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Histone Deacetylase Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Histone Deacetylase Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Histone Deacetylase Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Histone Deacetylase Inhibitors Players Market Share by Revenue in Histone Deacetylase Inhibitors 2015 & 2019
Figure 28. Histone Deacetylase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Histone Deacetylase Inhibitors Revenue Share by Type (2015-2020)
Figure 30. Global Histone Deacetylase Inhibitors Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Histone Deacetylase Inhibitors Revenue Share by Application (2015-2020)
Figure 32. Global Histone Deacetylase Inhibitors Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Histone Deacetylase Inhibitors Sales Market Share by Type in 2019
Figure 34. United States Histone Deacetylase Inhibitors Sales Market Share by Type in 2019
Figure 35. Europe Histone Deacetylase Inhibitors Sales Market Share by Company in 2019
Figure 36. Europe Histone Deacetylase Inhibitors Sales Market Share by Type in 2019
Figure 37. Europe Histone Deacetylase Inhibitors Sales Market Share by Application in 2019
Figure 38. China Histone Deacetylase Inhibitors Sales Market Share by Company in 2019
Figure 39. China Histone Deacetylase Inhibitors Sales Market Share by Type in 2019
Figure 40. China Histone Deacetylase Inhibitors Sales Market Share by Application in 2019
Figure 41. Japan Histone Deacetylase Inhibitors Sales Market Share by Company in 2019
Figure 42. Japan Histone Deacetylase Inhibitors Sales Market Share by Type in 2019
Figure 43. Japan Histone Deacetylase Inhibitors Sales Market Share by Application in 2019
Figure 44. Southeast Asia Histone Deacetylase Inhibitors Sales Market Share by Company in 2019
Figure 45. Southeast Asia Histone Deacetylase Inhibitors Sales Market Share by Type in 2019
Figure 46. Southeast Asia Histone Deacetylase Inhibitors Sales Market Share by Application in 2019
Figure 47. India Histone Deacetylase Inhibitors Sales Market Share by Company in 2019
Figure 48. India Histone Deacetylase Inhibitors Sales Market Share by Type in 2019
Figure 49. India Histone Deacetylase Inhibitors Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Histone Deacetylase Inhibitors
Figure 52. Manufacturing Process Analysis of Histone Deacetylase Inhibitors
Figure 53. Histone Deacetylase Inhibitors Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
ヒストンデアセチラーゼ（HDAC）阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Histone Deacetylase (HDAC) Inhibitors Market The global Histone Deacetylase (HDAC) Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Histone Deacetylase (HDAC) Inhibitors Sc…- レニン阻害剤の世界市場レポート2020 Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the …
- がんCDK阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Cancer CDK Inhibitors Market The global Cancer CDK Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Cancer CDK Inhibitors Scope and Market Size The global Cancer CDK Inhibi…
- プロトンポンプ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Proton Pump Inhibitors Market The global Proton Pump Inhibitors market size is projected to reach US$ 2750.5 million by 2026, from US$ 2404.3 million in 2020, at a CAGR of 2.3% during 2021-2026. Global Proton Pump Inhibitors Scope and Market Size The global Proto…
- 移行阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Migration Inhibitors Market The global Migration Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Migration Inhibitors Scope and Market Size The global Migration Inhibitors…